Home › Sakit na Sjögren › Maryland
Pag-aaral pangklinika para sa Sakit na Sjögren sa Maryland
7 pag-aaral para sa Sakit na Sjögren ang naghahanap ng mga kalahok sa mga site sa Maryland.
Opisyal na teksto ng pag-aaral (English)
Pain Phenotyping of Rheumatic Diseases - An Observational Study
- National Institutes of Health Clinical Center, Bethesda
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 9 hanggang 85 · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07829497Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT03816345The Myelin Disorders Biorepository Project
- Kennedy Krieger Institute, Baltimore
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT03047369The Pathogenesis and Natural History of Sjogren's Disease
- National Institutes of Health Clinical Center, Bethesda
Nagre-recruitObservasyonal na pag-aaral
Edad 16 hanggang 100 · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT01425892Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Primary Sjogren Disease
- National Institutes of Health Clinical Center, Bethesda
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Nob 2, 2026 · NCT07281456Characterization of Diseases With Salivary Gland Involvement
- National Institutes of Health Clinical Center, Bethesda
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 4 hanggang 100 · Lahat ng kasarian · Na-update Okt 27, 2026 · NCT02327884Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
- Arthritis and Rheumatism Associates, Rockville
Nagre-recruitPhase 3
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Okt 19, 2026 · NCT07404865Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.